7Medicines advisory statements

7  Medicines advisory statements

 (1) Subject to subsection (2), the advisory statements mentioned in column 4 of an item in the table in Schedule 1, are specified in relation to a medicine in a prescribed class that contains the substance described in column 2 of that item, in the circumstances set out in column 3 of that item, for the purposes of paragraph 3(5)(ca) of the Act.

Alternative statements

 (2) The following advisory statements are specified in relation to a medicine in a prescribed class for the purposes of paragraph 3(5)(ca) of the Act, as an alternative to the advisory statements specified in relation to the medicine by subsection (1):

 (a) the advisory statements specified by subsection (1) in relation to the medicine, as varied in a manner that does not change the intent of the advisory statements;

 (b) if more than one advisory statement is specified by subsection (1) in relation to the medicine—the advisory statements combined to form a simple sentence in a manner that does not change the intent of each advisory statement.

Note:  Unless otherwise specified in column 3 of the table in Schedule 1, the requirements only apply if the substance is included in the medicine as an active ingredient.